IGF1 and prostate cancer: Baseline PD-L1 surface expression in both Myc-CaP and 22Rv1 prostate cancer cells was low, and IGF-1 stimulation did not result in a clear increase in surface PD-L1 levels in 22Rv1 cells (Supplementary Figure S5B-C).